Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
1.920
-0.120 (-5.88%)
At close: Apr 1, 2025, 4:00 PM
2.080
+0.160 (8.33%)
After-hours: Apr 1, 2025, 7:03 PM EDT

Aprea Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
22.8521.6128.7953.08-
Cash & Short-Term Investments
22.8521.6128.7953.08-
Cash Growth
5.75%-24.94%-45.76%--
Prepaid Expenses
0.730.911.373.51-
Total Current Assets
23.5822.5230.1556.58-
Property, Plant & Equipment
0.080.0900.21-
Other Long-Term Assets
0.320.04-0.03-
Total Assets
23.9822.6530.1656.82-
Accounts Payable
1.351.670.841.77-
Accrued Expenses
2.012.192.365.35-
Current Portion of Leases
---0.19-
Current Unearned Revenue
-0.53---
Total Current Liabilities
3.364.393.27.32-
Total Liabilities
3.364.393.27.32-
Common Stock
0.01000-
Additional Paid-In Capital
350.97335.64330.06241-
Retained Earnings
-321.04-308.08-293.8-181.13-
Comprehensive Income & Other
-10.63-10.61-10.62-10.36-
Total Common Equity
19.3116.9525.6449.51-
Shareholders' Equity
20.6218.2626.9549.51-
Total Liabilities & Equity
23.9822.6530.1656.82-
Total Debt
---0.19-
Net Cash (Debt)
22.8521.6128.7952.89-
Net Cash Growth
5.75%-24.94%-45.57%--
Net Cash Per Share
4.155.9717.3749.69-
Filing Date Shares Outstanding
5.495.433.731.061.06
Total Common Shares Outstanding
5.483.742.661.061.06
Working Capital
20.2218.1426.9549.27-
Book Value Per Share
3.524.549.6645.97-
Tangible Book Value
19.3116.9525.6449.51-
Tangible Book Value Per Share
3.524.549.6645.97-
Machinery
0.150.140.050.14-
Updated Mar 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q